Immunogenic Thrombocytopenic Purpura
Conditions
Interventions
Group 1:YiQiJianPiSheXue Granule
Group 2:YiQiJianPiSheXue Granule +Prednisone
Group 3:Prednisone
Sponsors
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: The following 3 items should be conformed simultaneously: 1. subjects should be in accordance with the diagnosis of ITP; 2. subjects should be in accordance with the diagnosis of syndrome in TCM; 3. subjects should be voluntary participants and sign the informed consent form.
Exclusion criteria
Exclusion criteria: If the following any item is conformed: 1. combine with severe brain, liver or kidney disease; 2. mental disease; 3. subjects are pregnant or lactating women; 4. complicate with severe diabetes or hypertension; 5. allergic to the investigational medicine (single Chinese herb).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Chinese medical syndrome;Platelets;Bleeding; | — |
Secondary
| Measure | Time frame |
|---|---|
| White Blood Cell;Red Blood Cell;Hemoglobin;Hematokrit;Mean Corpuscular Volume;Red Bood Cell Distribution Width;Mean Platelet Volume;Platelet Distribution Width;Prothrombin Time;Prothrombin Ratio;Prothrombin Percent Activity;International Normalized Ratio;Activated Partial Thromboplastin Time;Fibrinogen Content;Thrombin Clotting Time;D-dimer;Creatinine;Blood Urea Nitrogen;ALT;AST;Total Bilirubin;Routine urine test;Stool routine;Electrocardiogram;Platelet Agglutination Test;Platelet Adhesion Test;Platelet Membrane Glycoprotein CD41;Platelet Membrane Glycoprotein CD61;Platelet Granule Membrane Protein GMP-140;Platelet Granule Membrane Protein CD62;T cell subgroup;Platelet Associated Immunoglobulin PAIgG;Platelet Associated Immunoglobulin PAIgA;Platelet Associated Immunoglobulin PAIgM; | — |
Countries
China
Contacts
Public ContactXinyi Chen
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Outcome results
None listed